Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis

Heymans, S. et al. (2006) Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation, 114, pp. 565-573. (doi: 10.1161/CIRCULATIONAHA.105.591032)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Baker, Professor Andrew
Authors: Heymans, S., Pauschinger, M., De Palma, A., Kallwellis-Opara, A., Rutschow, S., Swinnen, M., Vanhoutte, D., Gao, F., Torpai, R., Baker, A., Padalko, E., Neyts, J., Schultheiss, H., de Werf, F., Carmeliet, P., and Pinto, Y.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Circulation

University Staff: Request a correction | Enlighten Editors: Update this record